Tizanidine Tablet
Product Images NDC 71335-1799

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71335-1799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

FDA Label Image

Tizanidine-2 (Tizanidine 2)

FDA Label Image

Tizanidine-3 (Tizanidine 3)

FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
This is a clinical study that evaluates the improvement in Ashworth Score after the use of a medication with a mean dose of 26.8 mg. The study was conducted for 7 weeks, with the endpoint being the last observation carried forward.*
FDA Label Image

Label (Lbl713351799)

Label (Lbl713351799)
This is a label of a package of Zanaflex 2mg Tablet containing 30 tablets. It was packaged by Bryant Ranch Prepach Bunbank and has an expiration date of MM/YY. The tablets may cause dizziness or drowsiness and should be stored at room temperature (20°-25°C/68°-77°). The National Drug Code (NDC) of the package is 7133517991 and the product code is 03209301523487.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.